Damora Therapeutics, Inc. (DMRA)
Operating Expenses
$304.02M
TTM · Period ending: · USD

DMRA Operating Expenses
What is operating expenses?
Expenses from normal business operations (SG&A, R&D, etc.).
DMRA operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Operating Expenses (USD) | Change |
|---|---|---|
| 210,872,000 | +1,161.50% | |
| 16,716,000 | −53.08% | |
| 35,627,000 | −41.32% | |
| 60,717,000 | +17.25% | |
| 51,786,000 | +54.82% | |
| 33,448,999 | −13.92% | |
| 38,860,000 | +201.08% | |
| 12,907,000 | — |
Frequently asked questions: DMRA operating expenses
What is Damora Therapeutics, Inc. (DMRA)'s current operating expenses?
Damora Therapeutics, Inc. (DMRA)'s latest reported operating expenses (TTM) is $304.02M as of Sep 30, 2026. Expenses from normal business operations (SG&A, R&D, etc.).
How much historical operating expenses data is available for DMRA?
Stock Alarm Pro provides 8 dated annual fiscal periods observations for Damora Therapeutics, Inc. (DMRA)'s operating expenses, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare DMRA's operating expenses to peers or set an alert?
You can open DMRA's operating expenses in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on DMRA delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance